The purpose of this study is to measure the strength of breaths in patients with COPD using a device that mimics different inhalers.

Have you been diagnosed with B-Cell Lymphoma? Are you looking for options to treat your cancer? If so, you may be able to take part in a research study looking at the safety of giving a new drug called iC9-CAR19 with Rimiducid.

At the UNC At the Center of Excellence for Eating Disorders, our mission is to better understand the causes and consequences of eating disorders in order to develop better treatment options. In pursuit of this mission, we conduct several research studies each year. To conduct these research studies, we need help from volunteers - individuals who want to help us better understand eating disorders. You can help by volunteering to join our research registry. Anyone can join our registry. We welcome volunteers with no history of an eating disorder, as well as volunteers with a current or past history of an eating disorder.

Are you or someone you know related to an adult or child with Type 1 Diabetes? If so, you may eligible to participate in TrialNet.

The participant registry will assist with study recruitment for current and future studies at the UNC-CH Adams School of Dentistry.

The purpose of this study is to establish a safe dose of autologous CD138-CAR-T cells to infuse after lymphodepletion in adult patients with relapsed / refractory multiple myeloma.

Do you have Hodgkin's Lymphoma or Cutaneous T-Cell Lymphoma? Has your lymphoma come back, or has it not gotten better after your last treatment? If so, you might be able to take part in a study that will modify your own immune cells to see if it may treat your lymphoma.

Have you been diagnosed with a plasma cell disorder? You may be able to join a registry to help us learn more about the effects of plasma cell disorders on different aspects of life.

Have you been diagnosed with melanoma? If so, you may be eligible to take part in a research study looking at the safety of giving a combination of drugs called Ulixertinib and Palbociclib to patients with advanced melanoma.

Have you been diagnosed with Acute Lymphoblastic Leukemia? Has your leukemia come back or didn't get better after your last treatment? If so, you may be able to take part in a research study to learn more about the safety of modifying your own immune cells to treat your leukemia.